Earnings Reports
Filter News
Found 89,316 articles
-
Abbott Hosts Conference Call for Fourth-Quarter 2023 Earnings
1/3/2024
Abbott will announce its fourth-quarter 2023 financial results on Wednesday, Jan. 24, before the market opens.
-
QurAlis Strengthens Global Presence With Opening of European Headquarters That Includes R&D Manufacturing
1/3/2024
QurAlis Corporation announced the opening of its European Union headquarters in Leiden, The Netherlands.
-
Celularity Announces Net Sales and Total Revenue Expectations for Fourth Quarter 2023 and Full Year 2023
1/3/2024
Celularity Inc. announced expected net sales of its advance biomaterial products and biobanking businesses for the fourth quarter 2023 and the full year 2023 and expected total revenue for the fourth quarter 2023 and the full year 2023.
-
Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Revenues
1/3/2024
Profound Medical Corp. announced preliminary unaudited revenues for the fourth quarter and full year 2023, and provided an update on the progress it is making with the commercialization of TULSA-PRO® in the United States.
-
ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024
1/3/2024
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2024 on Wednesday, January 24, 2024, after the New York Stock Exchange closes.
-
Simulations Plus Reports First Quarter Fiscal 2024 Financial Results
1/3/2024
Simulations Plus, Inc. (NASDAQ: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first quarter fiscal 2024, ended November 30, 2023.
-
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2024
1/2/2024
Johnson & Johnson announced that its Board of Directors has declared a cash dividend for the first quarter of 2024 of $1.19 per share on the company’s common stock.
-
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2023 Financial Results and Provides Business Update
1/2/2024
Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products today reported business and financial results for the fiscal full year ended September 30, 2023.
-
Aptar Announces 2024 Quarterly Conference Call Dates
1/2/2024
AptarGroup, Inc., a global leader in drug and consumer product dosing, dispensing and protection technologies, announced the dates and times of quarterly conference calls for the year.
-
Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2024 on February 1
1/2/2024
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2024 on February 1 , prior to the opening of trading on the New York Stock Exchange.
-
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial Guidance at 8 a.m. ET on January 31, 2024
1/2/2024
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its fourth quarter and full year 2023 financial results, as well as on its financial guidance for 2024, on Wednesday, January 31, 2024, at 7:00 a.m. ET.
-
MIMEDX Provides AXIOFILL® Update & Reiterates 2023 Full Year Net Sales and Fourth Quarter Adjusted EBITDA Margin Outlook
12/29/2023
MiMedx Group, Inc. provided the following update regarding AXIOFILL and reiterated its outlook for 2023 full year net sales growth and fourth quarter adjusted EBITDA margin.
-
MedMira Reports First Quarter Results FY2024
12/29/2023
MedMira Inc., reported on its financial results for the quarter ended October 31, 2023.
-
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
12/27/2023
McKesson Corporation will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024.
-
Procaps Group Reports Third Quarter 2023 Results
12/26/2023
Procaps Group, S.A. announced its financial results for the three months ended September 30, 2023 and the nine months ended September 30, 2023.
-
CEL-SCI Reports Fiscal 2023 Financial Results and Clinical & Corporate Developments
12/22/2023
CEL-SCI Corporation (NYSE American: CVM) reported financial results for the fiscal year ended September 30, 2023, as well as key clinical and corporate developments.
-
Catheter Precision, Inc. Reports Third Quarter Results of Operations and Filing of Third Quarter 10-Q
12/22/2023
Catheter Precision, Inc. announced corporate highlights of the third quarter of 2023.
-
Kelyniam Global Releases 3rd Quarter 2023 Financials
12/21/2023
Kelyniam Global, a maker of custom cranial implants, announced results for its third quarter ended September 30, 2023.
-
Danaher Schedules Fourth Quarter 2023 Earnings Conference Call
12/21/2023
Danaher Corporation announced that it will webcast its quarterly earnings conference call for the fourth quarter 2023 on Tuesday, January 30, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour.
-
Dentsply Sirona Declares Quarterly Cash Dividend - December 21, 2023
12/21/2023
DENTSPLY SIRONA Inc. announced that its Board of Directors declared a quarterly cash dividend of $0.14 per share of common stock, an indicated annual rate of $0.56 per share.